162 related articles for article (PubMed ID: 11068141)
41. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
[TBL] [Abstract][Full Text] [Related]
42. Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats.
Takahashi C; Ohata H; Shibasaki T
Peptides; 2011 Dec; 32(12):2384-93. PubMed ID: 21964377
[TBL] [Abstract][Full Text] [Related]
43. Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus.
Parkes D; Rivest S; Lee S; Rivier C; Vale W
Mol Endocrinol; 1993 Oct; 7(10):1357-67. PubMed ID: 8264665
[TBL] [Abstract][Full Text] [Related]
44. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
[TBL] [Abstract][Full Text] [Related]
45. Sex-dependent and differential responses to acute restraint stress of corticotropin-releasing factor-producing neurons in the rat paraventricular nucleus, central amygdala, and bed nucleus of the stria terminalis.
Sterrenburg L; Gaszner B; Boerrigter J; Santbergen L; Bramini M; Roubos EW; Peeters BW; Kozicz T
J Neurosci Res; 2012 Jan; 90(1):179-92. PubMed ID: 21922520
[TBL] [Abstract][Full Text] [Related]
46. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons.
Sakamoto F; Yamada S; Ueta Y
Regul Pept; 2004 May; 118(3):183-91. PubMed ID: 15003835
[TBL] [Abstract][Full Text] [Related]
47. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
[TBL] [Abstract][Full Text] [Related]
48. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
Henry BA; Lightman SL; Lowry CA
J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
[TBL] [Abstract][Full Text] [Related]
49. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
50. Fourth ventricular CART peptide induces c-fos in the area postrema and nucleus of the solitary tract via a CRF-receptor dependent mechanism.
Smedh U; Scott KA; Moran TH
Neurosci Lett; 2015 Nov; 609():124-8. PubMed ID: 26475505
[TBL] [Abstract][Full Text] [Related]
51. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors.
Schmidt ED; Aguilera G; Binnekade R; Tilders FJ
Neuroscience; 2003; 116(1):275-83. PubMed ID: 12535959
[TBL] [Abstract][Full Text] [Related]
52. Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2.
Cottone P; Sabino V; Nagy TR; Coscina DV; Zorrilla EP
J Physiol; 2007 Sep; 583(Pt 2):487-504. PubMed ID: 17627984
[TBL] [Abstract][Full Text] [Related]
53. Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats.
Wang L; Martínez V; Vale W; Taché Y
Brain Res; 2000 Feb; 855(1):47-57. PubMed ID: 10650129
[TBL] [Abstract][Full Text] [Related]
54. Chronic corticotropin-releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded rats.
Lawrence AJ; Parish CL; Chen F; Lodge DJ; Krstew EV; Card K; Finkelstein DI; Horne MK
J Neurochem; 2005 Sep; 94(6):1523-34. PubMed ID: 16000149
[TBL] [Abstract][Full Text] [Related]
55. Corticotropin-releasing factor type-2 receptor and corticotropin-releasing factor-binding protein coexist in rat ventral tegmental area nerve terminals originated in the lateral hypothalamic area.
Slater PG; Noches V; Gysling K
Eur J Neurosci; 2016 Jan; 43(2):220-9. PubMed ID: 26503565
[TBL] [Abstract][Full Text] [Related]
56. Corticotropin-Releasing Factor Mediates Pain-Induced Anxiety through the ERK1/2 Signaling Cascade in Locus Coeruleus Neurons.
Borges GP; Micó JA; Neto FL; Berrocoso E
Int J Neuropsychopharmacol; 2015 Feb; 18(8):. PubMed ID: 25716783
[TBL] [Abstract][Full Text] [Related]
57. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
58. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
59. Expression of c-fos mRNA in rat brain after intracerebroventricular administration of corticotropin-releasing hormone.
Clark M; Weiss SR; Post RM
Neurosci Lett; 1991 Nov; 132(2):235-8. PubMed ID: 1784425
[TBL] [Abstract][Full Text] [Related]
60. The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
Traver S; Marien M; Martin E; Hirsch EC; Michel PP
Mol Pharmacol; 2006 Jul; 70(1):30-40. PubMed ID: 16569708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
